Danah Majorie Lucasan, NP
Family · Rancho Cucamonga, CANPI 1669030987
Payments from drug & device makers
Across 107 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$721
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$297
- Collegium Pharmaceutical, Inc.$264
- AbbVie$234
- Boston Scientific$185
- Scilex Pharmaceuticals Inc.$120
- plus $692 from 14 others
What the payments were for
- Travel & lodging$27111%
- Food & beverage$2,17887%
- Education$633%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $721 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $297 |
| Collegium Pharmaceutical, Inc. | 18 | $264 |
| AbbVie(2 entities) | 9 | $234 |
| Boston Scientific | 9 | $185 |
| Scilex Pharmaceuticals Inc. | 6 | $120 |
| Azurity Pharmaceuticals, Inc. | 6 | $115 |
| Painteq LLC | 5 | $112 |
| Virtus Pharmaceuticals LLC | 4 | $78 |
| Hikma Pharmaceuticals USA | 3 | $63 |
| GRT US Holding, Inc. | 3 | $63 |
| Spinal Simplicity, LLC | 3 | $61 |
| Forte Bio-pharma LLC | 2 | $43 |
| Valinor Pharma, LLC | 2 | $38 |
| Nevro Corp. | 1 | $25 |
| SPR Therapeutics, Inc | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Curonix LLC | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,512 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 70 | $33,451 |
| RelistorMethylnaltrexone Bromide | 13 | $30,607 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,470 | $26,593 |
| MovantikNaloxegol Oxalate | 39 | $16,163 |
| Xtampza ErOxycodone Myristate | 35 | $15,671 |
| Lidocaine | 199 | $15,343 |
| ZtlidoLidocaine | 33 | $12,951 |
| Pregabalin | 480 | $11,950 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 363 | $9,601 |
| Gabapentin | 803 | $9,187 |
| Buprenorphine | 37 | $7,987 |
| LinzessLinaclotide | 14 | $7,798 |
| OxycontinOxycodone Hcl | 13 | $7,573 |
| Fentanyl | 87 | $7,117 |
| Celecoxib | 65 | $4,064 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $264 | $49,122105 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $297 | $30,60713 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $120 | $12,95133 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $63 | $8,36759 claims |
| AbbVieLinzess | $234 | $7,79814 claims |
| Virtus Pharmaceuticals LLCLactulose | $78 | $33017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Rancho Cucamonga
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.